Pharmaceutical fresh frozen plasma
ApprovedBiologic
Pharmaceutical fresh frozen plasma is one of 26 biologic programs targeting Sepsis. It is currently in Approved.
1
Indications
1
Total Trials
1
Active Trials
25
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
308 competitors in Sepsis
#DrugCompanyPhaseTrials
1Pharmaceutical fresh frozen plasma
FFundación Cardioinfantil Instituto de Cardiología
Approved
Corlanor
AmgenPreclinical
Simdax
Orion Corporation, Orion PharmaPreclinical
Zyvox
PfizerPreclinical
Zemplar
AbbViePreclinical
Brevibloc
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Levophed
GGeneral Hospital of Ningxia Medical University
Preclinical
Jardiance
Boehringer IngelheimPreclinical
Micardis
Boehringer IngelheimPreclinical
Achromycin V
WWyeth-Lederle Vaccines
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sepsis1 trial
Randomized Control Study in REsuscitation of SEpsis Trial
Not yet recruiting·FFundación Cardioinfantil Instituto de Cardiología·Phase 4·NCT07035509·150 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details